Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Cancer Genetics Q1 Revenues Fall 11 Percent

Cancer Genetics Q1 Revenues Fall 11 Percent

May 21, 2019
|
staff reporter

NEW YORK (GenomeWeb) — Cancer Genetics reported after the close of the market on Monday an 11 percent drop in first quarter revenues as improved performance by its biopharma services operations was more than offset by declines in clinical and discovery services revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Featured Webinar

Demystifying COVID-19 Antibody Testing

Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18
Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. Germany Starts Going After Coronavirus Cases With Free Testing for Returning Travelers

    Premium

  2. Luminex Responds to FDA Warning Letter While Ramping SARS-CoV-2 Test Manufacturing

    Premium

  3. NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK

  4. Illumina Sees Expanding Sequencing Market in COVID-19 Response, Despite Short-Term Woes

    Premium

  5. Vela Diagnostics, Capstone Healthcare Get FDA Emergency Use Authorization for Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.